Cargando…

Evaluation of the irritable bowel syndrome severity index in Japanese male patients with irritable bowel syndrome with diarrhea

BACKGROUND: Previous studies have indicated that ramosetron, a 5-hydroxytryptamine-3 receptor antagonist, achieves global improvement in irritable bowel syndrome (IBS) symptoms in male patients with IBS with diarrhea (IBS-D). However, in addition to global assessment it was deemed important to asses...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ida, Motoko, Nishida, Akito, Akiho, Hiraku, Nakashima, Yoshihiro, Matsueda, Kei, Fukudo, Shin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346243/ https://www.ncbi.nlm.nih.gov/pubmed/28293280 http://dx.doi.org/10.1186/s13030-017-0092-x

Ejemplares similares

Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea
por: Ida, Motoko, et al.
Publicado: (2017)

Epidemiology of irritable bowel syndrome
por: Endo, Yuka, et al.
Publicado: (2015)

Impact of symptoms by gender and age in Japanese subjects with irritable bowel syndrome with constipation (IBS-C): a large population-based internet survey
por: Kosako, Masanori, et al.
Publicado: (2018)

Biopsychosocial Model of Irritable Bowel Syndrome
por: Tanaka, Yukari, et al.
Publicado: (2011)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Influence of the requirement for abdominal pain in the diagnosis of irritable bowel syndrome with constipation (IBS-C) under the Rome IV criteria using data from a large Japanese population-based internet survey
por: Kosako, Masanori, et al.
Publicado: (2018)

Abdominal bloating is the most bothersome symptom in irritable bowel syndrome with constipation (IBS-C): a large population-based Internet survey in Japan
por: Kanazawa, Motoyori, et al.
Publicado: (2016)

Targeted therapies for diarrhea-predominant irritable bowel syndrome
por: Olden, Kevin W
Publicado: (2012)

Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome
por: Lacy, Brian E
Publicado: (2016)

Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
por: Özdener, Ayşe Elif, et al.
Publicado: (2017)

Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea
por: Cash, Brooks D, et al.
Publicado: (2017)

Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
por: Fukudo, Shin, et al.
Publicado: (2021)

Irritable Bowel Syndrome
por: Farup, Per G., et al.
Publicado: (2012)

Effects of personality traits on the manifestations of irritable bowel syndrome
por: Tayama, Jun, et al.
Publicado: (2012)

Spotlight on eluxadoline for the treatment of patients with irritable bowel syndrome with diarrhea
por: Fragkos, Konstantinos C
Publicado: (2017)

Diarrhea-Predominant Irritable Bowel Syndrome: Medical Management Update
por: Andrews, Christopher N, et al.
Publicado: (2019)

Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea
por: Colomier, Esther, et al.
Publicado: (2021)

A neurological approach to biopsychosocial medicine: Lessons from irritable bowel syndrome
por: Fukudo, Shin
Publicado: (2011)

Correction: Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
por: Fukudo, Shin, et al.
Publicado: (2023)

Misinterpreting Diarrhea-Predominant Irritable Bowel Syndrome and Functional Diarrhea: Pathophysiological Highlights
por: Sciumè, Giusi Desirè, et al.
Publicado: (2023)

Gastrointestinal specific anxiety in irritable bowel syndrome: validation of the Japanese version of the visceral sensitivity index for university students
por: Saigo, Tatsuo, et al.
Publicado: (2014)

Staple Foods Consumption and Irritable Bowel Syndrome in Japanese Adults: A Cross-Sectional Study
por: Zheng, Zhaoqiu, et al.
Publicado: (2015)

Comparison of Quality of Life and Psychiatric Symptoms Between Patients With Diarrhea-Predominant Irritable Bowel Syndrome and Those With Constipation-Predominant Irritable Bowel Syndrome
por: BOUSABA, J., et al.
Publicado: (2023)

Cultural adaptation: translatability assessment and linguistic validation of the patient-reported outcome instrument for irritable bowel syndrome with diarrhea
por: Delgado-Herrera, Leticia, et al.
Publicado: (2016)

Second Asian Consensus on Irritable Bowel Syndrome
por: Gwee, Kok Ann, et al.
Publicado: (2019)

Is irritable bowel syndrome a dysbiotic bowel syndrome?
por: Benno, Peter, et al.
Publicado: (2015)

ALEXITHYMIA IN IRRITABLE BOWEL SYNDROME
por: Arun, Priti
Publicado: (1998)

Probiotics and irritable bowel syndrome
por: Korpela, Riitta, et al.
Publicado: (2012)

The epidemiology of irritable bowel syndrome
por: Canavan, Caroline, et al.
Publicado: (2014)

Diet in irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2015)

Genetics of irritable bowel syndrome
por: Henström, Maria, et al.
Publicado: (2016)

Biomarkers of Irritable Bowel Syndrome
por: Kim, Jae Hak, et al.
Publicado: (2017)

Bloating in irritable bowel syndrome
por: Safaee, Azadeh, et al.
Publicado: (2011)

Pharmacotherapy for Irritable Bowel Syndrome
por: Camilleri, Michael, et al.
Publicado: (2017)

Irritable Bowel Syndrome and Synbiotics
por: Kim, Soo Young
Publicado: (2019)

Irritable bowel syndrome diagnosis
por: Tyllis, Nick
Publicado: (2019)

Irritable bowel syndrome and diet
por: Portincasa, Piero, et al.
Publicado: (2017)

Postinfection Irritable Bowel Syndrome
por: Ghoshal, Uday C
Publicado: (2022)

The neurobiology of irritable bowel syndrome
por: Mayer, Emeran A., et al.
Publicado: (2023)

Irritable Bowel Syndrome and Antidepressants
por: Curtiss, Frederic R.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_i4qdcg21fgj33lgfiosiif7p42